Continuous hyperfractionated accelerated radiotherapy (CHART) using volumetric modulated arc therapy (VMAT) for locally advanced non-small cell lung cancer (NSCLC) - the clinical experience

被引：1
|
作者：
Shrimali, R. [1 ]
Sen, P. [1 ]
Arunsingh, M. [1 ]
Mahata, A. [2 ]
Mallick, I. [1 ]
Prasath, S. [2 ]
Achari, R. [1 ]
Chatterjee, S. [1 ]
机构：
[1] Tata Med Ctr, Radiat Oncol, Kolkata, India
[2] Tata Med Ctr, Kolkata, India
来源：
LUNG CANCER | 2016年 / 91卷
关键词：
D O I：
10.1016/S0169-5002(16)30138-6
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
121
引用
收藏
页码：S43 / S44
页数：2
相关论文
共 50 条
  • [31] Continuous, hyperfractionated, accelerated radiotherapy (CHART) in non-small cell lung cancer: Pooled results from 5 UK centres
    Din, O.
    Hatton, M.
    Cameron, A.
    Lester, J.
    Moore, B.
    Erridge, S.
    Ironside, J.
    Warnock, J.
    Gee, A.
    Falk, S.
    Klinsman, J.
    Morgan, S.
    Worvill, J.
    RADIOTHERAPY AND ONCOLOGY, 2006, 81 : S192 - S192
  • [32] Clinical Outcomes of Chemoradiotherapy Using Volumetric Modulated Arc Therapy (VMAT) for Locally Advanced Esophageal Cancer: A Single Institute Experience
    Famed, M. M.
    Shaikh, P. M., Jr.
    Raza, S. M.
    Abubakar, M.
    Amjad, N.
    Afzal, A.
    Fatima, H.
    Mughal, M.
    Clump, D. A., II
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2024, 120 (02): : E442 - E442
  • [33] Comment on: "Escalated hyperfractionated accelerated radiation therapy for locally advanced non-small cell lung cancer: a clinical phase II trial"
    Cengiz, M
    Selek, U
    Yildiz, F
    Sari, S
    RADIOTHERAPY AND ONCOLOGY, 2005, 74 (01) : 76 - 77
  • [34] Dosimetric and Clinical Benefits of Conformal Radiotherapy Plus Volumetric Modulated Arc Therapy in the Treatment of Non-small Cell Lung Cancer
    Jin, Xiance
    Xie, Congying
    WORLD CONGRESS ON MEDICAL PHYSICS AND BIOMEDICAL ENGINEERING, 2015, VOLS 1 AND 2, 2015, 51 : 392 - 396
  • [35] Dosimetric and Clinical Benefits of Conformal Radiotherapy Plus Volumetric Modulated Arc Therapy in the Treatment of Non-Small Cell Lung Cancer
    Jin, X.
    Xie, C.
    MEDICAL PHYSICS, 2015, 42 (06) : 3704 - 3705
  • [36] The therapy of locally advanced non-small cell lung cancer (NSCLC) in the elderly
    Schild, S. E.
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2006, 60 : S7 - S7
  • [37] Hyperfractionated accelerated radiotherapy with doze escalation in non-small cell lung cancer
    Zolotkov, Alexey G.
    Mardynsky, Yury S.
    Ragulin, Yury A.
    Medvedev, Victor N.
    JOURNAL OF THORACIC ONCOLOGY, 2009, 4 (09) : S954 - S955
  • [38] INDUCTION CHEMOTHERAPY AND CONTINUOUS HYPERFRACTIONATED ACCELERATED RADIOTHERAPY (CHART) FOR PATIENTS WITH LOCALLY ADVANCED INOPERABLE NON SMALL-CELL LUNG CANCER: THE MRC INCH RANDOMIZED TRIAL
    Hatton, Matthew
    Nankivell, Matthew
    Lyn, Ethan
    Falk, Stephen
    Pugh, Cheryl
    Navani, Neal
    Stephens, Richard
    Parmar, Mahesh
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2011, 81 (03): : 712 - 718
  • [39] Original association of chemo and radiotherapy for locally advanced non-small cell lung cancer (NSCLC): LIEGE experience
    Bosquee, L
    Bustin, F
    Gustin, M
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 698S - 698S
  • [40] Continuous, hyperfractionated, accelerated radiotherapy (CHART) versus conventional radiotherapy in non-small cell lung cancer: mature data from the randomised multicentre trial
    Saunders, M
    Dische, S
    Barrett, A
    Harvey, A
    Griffiths, G
    Parmar, M
    RADIOTHERAPY AND ONCOLOGY, 1999, 52 (02) : 137 - 148
12345